Long COVID Fatigue
Autor Thorsten Rudroffen Limba Engleză Hardback – 27 apr 2025
Preț: 827.21 lei
Preț vechi: 1074.29 lei
-23%
Puncte Express: 1241
Carte tipărită la comandă
Livrare economică 01-07 decembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9783031894732
ISBN-10: 3031894731
Pagini: 204
Dimensiuni: 160 x 241 x 16 mm
Greutate: 0.46 kg
Editura: Springer
ISBN-10: 3031894731
Pagini: 204
Dimensiuni: 160 x 241 x 16 mm
Greutate: 0.46 kg
Editura: Springer
Notă biografică
Thorsten Rudroff is a Professor (Docent) in Experimental Neuroimaging at the Turku PET Centre, University of Turku and Turku University Hospital, Finland. He previously held positions as Associate Professor at the University of Iowa and Assistant Professor at Colorado State University, USA. With over 20 years of experience in neurophysiology research, he has made significant contributions to understanding fatigue and cognitive dysfunction in neurological disorders, particularly in Multiple Sclerosis and Long COVID. His scientific work includes over 90 publications in prestigious journals and the Springer book "Long COVID Fatigue," which addresses the neurological underpinnings of this prevalent post-viral syndrome. Dr. Rudroff received his Ph.D. in Neurophysiology from the University of Constance, Germany, and completed his postdoctoral training at the University of Colorado, Boulder. He is particularly passionate about leveraging artificial intelligence to advance medical research and improve patient outcomes. Dr. Rudroff serves on multiple editorial boards and has received several significant research grants from the National Institutes of Health. His current research focuses on the intersection of neuroimaging, artificial intelligence, and Long COVID, with particular emphasis on developing innovative approaches to understand and treat fatigue symptoms. Furthermore, his focus is on developing AI-driven approaches for early detection of Alzheimer’s disease through neuroimaging biomarkers.